Clinical efficacy and safety of a single administration of fluralaner injectable suspension (BRAVECTO® injectable) vs. monthly administration of oral afoxolaner (NexGard®) in dogs for tick and flea control over one year under European field conditions

Clinical efficacy and safety of a single administration of fluralaner injectable suspension (BRAVECTO® injectable) vs. monthly administration of oral afoxolaner (NexGard®) in dogs for tick and flea control over one year under European field conditions

Abstract Background Year-round control of canine flea and tick infestations requires owner compliance with recommendations for regular treatments. Compliance failures can result in increased exposure of dogs to tick-borne pathogens and resurgence of flea populations. This study investigated the year...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivo Petersen, Susanne Goebel-Lauth, Thierry Pobel, Maria J. Gil, Wolfgang Löhlein, Oliver Wolf, Eva Zschiesche, Bjoern Welzel, Lea Heinau
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Parasites & Vectors
Subjects:
Afoxolaner
Bravecto® injectable
Dog
Flea
Ticks
Fluralaner
Online Access:https://doi.org/10.1186/s13071-024-06590-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13071-024-06590-1

Similar Items